Melatonin role in the mitochondrial function

被引:120
作者
Acuna-Castroviejo, Dario [1 ]
Escames, Germaine [1 ]
Rodriguez, Maria I. [1 ]
Lopez, Luis C. [1 ]
机构
[1] Univ Granada, Fac Med, Dept Fisiol, Inst Biotecnol, E-18012 Granada, Spain
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2007年 / 12卷
关键词
melatonin; melatonin metabolites mitochondria; antioxidant; oxidative stress; reactive oxygen species; reactive nitrogen species; excitotoxicity; mitochondrial dysfunction; mitochondrial diseases; neurodegeneration; review;
D O I
10.2741/2116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melatonin is an ancient molecule present in unicellular organisms at the very early moment of life. Initially identified as a secretory product of the pineal gland in mammals and in other species, it was considered a hormone related to reproduction. The evidence that melatonin is produced in many organs and tissues of the body, reaching concentrations higher than in the blood, support the multiplicity of the melatonin actions. The best-known actions of melatonin, currently supported by experimental and clinical data, include antioxidant and anti-inflammatory abilities, some of them involving genomic regulation of a series of enzymes. Besides, melatonin displays anticonvulsant and antiexcitotoxic properties. Most of the beneficial consequences resulting from melatonin administration may depend on its effects on mitochondrial physiology. The physiological effects of melatonin on normal mitochondria, its role to prevent mitochondrial impairment, energy failure, and apoptosis in oxidatively-damaged mitochondria, and the beneficial effects of the administration of melatonin in experimental and clinical diseases involving mitochondrial dysfunction and cell death, are revised.
引用
收藏
页码:947 / 963
页数:17
相关论文
共 106 条
  • [91] Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia
    Schapira, AHV
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02): : 159 - 170
  • [92] DISTINCT EFFECTS OF THIOREDOXIN AND ANTIOXIDANTS ON THE ACTIVATION OF TRANSCRIPTION FACTORS NF-KAPPA-B AND AP-1
    SCHENK, H
    KLEIN, M
    ERDBRUGGER, W
    DROGE, W
    SCHULZEOSTHOFF, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) : 1672 - 1676
  • [93] Seabra WDV, 2000, J PINEAL RES, V29, P193
  • [94] Skulachev Vladimir P., 1999, Molecular Aspects of Medicine, V20, P139, DOI 10.1016/S0098-2997(99)00008-4
  • [95] The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
    Slominski, A
    Wortsman, J
    Tobin, DJ
    [J]. FASEB JOURNAL, 2005, 19 (02) : 176 - 194
  • [96] Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat
    Stefulj, J
    Hörtner, M
    Ghosh, M
    Schauenstein, K
    Rinner, I
    Wölfler, A
    Semmler, J
    Liebmann, PM
    [J]. JOURNAL OF PINEAL RESEARCH, 2001, 30 (04) : 243 - 247
  • [97] N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant
    Tan, DX
    Manchester, LC
    Burkhardt, S
    Sainz, RM
    Mayo, JC
    Kohen, R
    Shohami, E
    Huo, YS
    Hardeland, R
    Reiter, RJ
    [J]. FASEB JOURNAL, 2001, 15 (10) : 2294 - +
  • [98] High physiological levels of melatonin in the bile of mammals
    Tan, DX
    Manchester, LC
    Reiter, RJ
    Qi, WB
    Hanes, MA
    Farley, NJ
    [J]. LIFE SCIENCES, 1999, 65 (23) : 2523 - 2529
  • [99] A novel melatonin metabolite, cyclic 3-hydroxymelatonin:: A biomarker of in vivo hydroxyl radical generation
    Tan, DX
    Manchester, LC
    Reiter, RJ
    Plummer, BF
    Hardies, LJ
    Weintraub, ST
    Vijayalaxmi
    Shepherd, AMM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) : 614 - 620
  • [100] Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137